Moreover, using a TCGA dataset from 177 pancreatic cancer patients, we confirmed that higher/lower KLF5 expression is predictive of poorer/better overall and tumor-free survival, and that KLF5 is the key determinant of survival time in pancreatic cancer patients. Here, KLF5 is linked to familial pancreatic carcinoma.